Cellino, a company developing a platform to automate stem cell production, presented today at TechCrunch Disrupt 2021’s Startup Battlefield to detail how its system, which combines AI technology, machine learning, hardware, software — and yes, lasers! — could eventually democratize access to cell therapies. It aims to bring down costs associated with the manufacturing of … Continue reading Cellino is using AI and machine learning to scale production of stem cell therapies